A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...
SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...
A class of drugs used to treat diabetes has been linked to a 20% lower risk of dementia and Parkinson's disease. | ...
A new study by scientists at Nottingham Trent University will use non-invasive techniques to investigate the targeted ...
New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.
The project, by scientists at Nottingham Trent University, will look at whether treatment can be delivered to the brain via ...
MSIG Insurance, a provider of general insurance solutions in Asia and part of the MS&AD Insurance Group, has introduced ...
By The Daily Edition 37 new cases of Parkinson's disease are diagnosed every single day - yet we still don't know the cause, and there is no cure. Even more concerning, the number of people living ...